Veri Medtech Holdings, Inc. VRHI
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -16.16% | 12.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.16% | 12.15% | |||
| Cost of Revenue | -5.49% | 3.79% | |||
| Gross Profit | -19.46% | 15.02% | |||
| SG&A Expenses | -10.26% | -23.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.20% | -18.40% | |||
| Operating Income | -106.62% | 85.25% | |||
| Income Before Tax | -84.55% | 84.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -48.10% | 80.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.10% | 80.30% | |||
| EBIT | -106.62% | 85.25% | |||
| EBITDA | -107.88% | 85.40% | |||
| EPS Basic | -48.00% | 80.30% | |||
| Normalized Basic EPS | -98.40% | 84.24% | |||
| EPS Diluted | -48.00% | 80.30% | |||
| Normalized Diluted EPS | -98.40% | 84.24% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||